Abstract
Aims: The objective of the present investigation was to identify the hematological profile of β-thalassemia trait.
Methods: The cross-sectional investigation, which included 186 patients, was conducted in a tertiary care hospital’s hematology unit of the pathology department from November 2012 to May 2014.
Results: About 73.11% of the study population was in the 21–50 years age group followed by 18.27% in the age group 0–20 years. About 8.62% of the study population was in between 51 and 75 years of age. Eighty-six (46.23%) men and 100 (53.77%) women made up the study’s sample. In our study, India had a 19% overall prevalence of the thalassemia trait. In the research, we conducted we found that those with the beta-thalassemia trait (BTT) had much lower levels of red blood cells (RBC) parameters except RBC count which is slightly raised than those without the trait.
Conclusion: There is a significant prevalence of BTT in our population. This information will prove helpful to health policy managers in making informed decisions on how to design accessible screening programs for BTT.
Publisher
Innovare Academic Sciences Pvt Ltd
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology